Details werden geladen...
Semaglutide and Ozempic-like drugs may improve kidney disease outcomes - ABC News
Research shows semaglutide — commonly sold as Ozempic or Wegovy — can improve kidney function and survival rates for people with some chronic diseases, even if they have heart issues.
Ähnliche Seiten
Popular GLP-1 weight-loss drugs like Ozempic slash heart attack and stroke risk | ScienceDaily
https://www.sciencedaily.com/releases/2026/05/260520093731.htm
GLP-1 drugs may result in better outcomes for cancer patients, study claims | The Independent
https://www.independent.co.uk/news/world/americas/glp-1-drugs-cancer-study-b2981601.html
Weight loss drugs and nutrient deficiency: What nutrients are GLP-1 users lacking?
https://timesofindia.indiatimes.com/etimes/wellness/weight-loss-drugs-and-nutrient-deficiency-what-nutrients-are-glp-1-users-lacking/photostory/131292164.cms
Weight Loss on GLP-1 Drugs Linked to Lower Risk of Disease, Study Finds : ScienceAlert
https://www.sciencealert.com/weight-loss-on-glp-1-drugs-linked-to-lower-risk-of-disease-study-findsScientists discover why Ozempic and Wegovy weight loss eventually plateaus | ScienceDaily
https://www.sciencedaily.com/releases/2026/05/260525000453.htm